Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.210
-0.070 (-5.47%)
At close: Apr 9, 2026, 4:00 PM EDT
1.215
+0.005 (0.41%)
Pre-market: Apr 10, 2026, 4:32 AM EDT
DRMA's stock price has decreased by -85.56% in the past year and price targets may not have had time to catch up.
Dermata Therapeutics Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$10.00
Upside
+726.45%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $30 → $10 | Strong Buy | Maintains | $30 → $10 | +726.45% | Aug 21, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $60 → $30 | Strong Buy | Maintains | $60 → $30 | +2,379.34% | May 21, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $100 → $60 | Strong Buy | Maintains | $100 → $60 | +4,858.68% | Aug 21, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $2,400 → $600 | Strong Buy | Maintains | $2,400 → $600 | +49,486.78% | Mar 23, 2023 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $33,600 | Strong Buy | Initiates | $33,600 | +2,776,759.50% | Sep 21, 2021 |
| Maxim Group | Maxim Group | Strong Buy Initiates $21,600 | Strong Buy | Initiates | $21,600 | +1,785,023.97% | Sep 14, 2021 |